A clinical trial testing Esperion Therapeutics’ Bempedoic acid with the actives in Merck’s Zetia and Pfizer’s Lipitor has concluded with successful results. Patients taking part in the study reported an average of 64% decrease in LDL cholesterol. These results have...
Lupin has received an FDA approval for its cholesterol drug, Nikita Pitavastatin. The drug, which received a new drug approval from the agency, is poised as the latest treatment for patients suffering from primary hyperlipidemia or mixed dyslipidemia by lowering total...
Aum Cardiovascular has secured FDA approval for its cardiovascular device, Cadance. The device, which is to be used in a primary care setting, applies an algorithm to the natural acoustics of the heart. This will allow doctors to adequately diagnose patients without...
Abiomed has announced a rise in shares due to a less-than-expected CMS cut to reimbursements for the company’s heart pump, Impella. The Centers for Medicaid and Medicare Services initially proposed a 35% cut to reimbursement, but only 19% was actually implemented....
Have You Secured Coverage in 2018? How PBMs Hold the Key to Pharmaceutical Success Recent debates surrounding drug pricing have forced the pharmaceutical industry to navigate multiple avenues ensuring optimal coverage while maintaining high levels of ROI. Though the...
